CRISPR is the gene-altering super tool that a lot of scientists have been itching to take for a spin and now, it seems one group has managed to create something rather interesting. They basically turned the bacteria strain known as Escherichia coli (E. coli) into a microscopic tape recorder. This could potentially turn the deadly germ into a medical spy.
Although this news might seem like scientists playing around, it can actually have a much bigger impact on the medical industry. What the researchers from the Columbia University Medical Center (CUMC) achieved is essentially allowing doctors to record the changes that the patient’s body undergo when the E. coli enters their system.
They chose the bacteria specifically because it can retain information, Futurism reports. As CUMC Departments of Pathology & Cell Biology and Systems Biology assistant professor, Harris Wang explains, it could provide a view into a microscopic world that doctors have never seen before.
“Such bacteria, swallowed by a patient, might be able to record the changes they experience through the whole digestive tract, yielding an unprecedented view of previously inaccessible phenomena,” Wang said.
Now, before anyone gets the wrong idea here, the genetically modified E. coli does not actually record visual data. It does not act like a smartphone camera. Rather, it simply stores information that could give scientists an idea of what transpired in the body as it was happening when the bacteria passed through, Science Alert reports.
This development could only lead to further advancements in the field of genetic engineering and medicine, as well as other fields that CRISPR could be used in. The gene-editing tool is proving to be more and more revolutionary with every new discovery made using it. This particular case could actually provide doctors with days’ worth of data on the changes inside the bodies of patients.


NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay
Neuralink Expands Brain Implant Trials with 12 Global Patients
NASA Faces Major Workforce Reduction as 20% of Employees Prepare to Leave
Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Tabletop particle accelerator could transform medicine and materials science
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 



